Cargando…
Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer
Pancreatic cancer is the eighth most common cause of death from cancer in the world, for which palliative treatments are not effective and frequently accompanied by severe side effects. We propose a DNA-based therapy for pancreatic cancer using a nonviral vector, expressing the diphtheria toxin A ch...
Autores principales: | Scaiewicz, V., Sorin, V., Fellig, Y., Birman, T., Mizrahi, A., Galula, J., Abu-lail, R., Shneider, T., Ohana, P., Buscail, L., Hochberg, A., Czerniak, A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967839/ https://www.ncbi.nlm.nih.gov/pubmed/21052499 http://dx.doi.org/10.1155/2010/178174 |
Ejemplares similares
-
Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences
por: Mizrahi, Aya, et al.
Publicado: (2009) -
Treatment of ovarian cancer ascites by intra-peritoneal injection of diphtheria toxin A chain-H19 vector: a case report
por: Mizrahi, Aya, et al.
Publicado: (2010) -
H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer
por: Sorin, Vladimir, et al.
Publicado: (2012) -
The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention
por: Matouk, Imad, et al.
Publicado: (2013) -
The H19 Non-Coding RNA Is Essential for Human Tumor Growth
por: Matouk, Imad J., et al.
Publicado: (2007)